nicotinamide (a vitamin B3, NMN)

From Aaushi
Jump to navigation Jump to search
[1][2][3][4]

Indications

Contraindications

Dosage

Comparative biology

More general terms

More specific terms

Additional terms

Component of

References

  1. ↑ 1.0 1.1 1.2 Martin AJ et al Oral nicotinamide to reduce actinic cancer: A phase 3 double-blind randomized controlled trial. American Society of Clinical Oncology (ASCO) 2015 Annual Meeting http://abstracts.asco.org/156/AbstView_156_149209.html
  2. ↑ 2.0 2.1 Chen AC, Martin AJ, Choy B et al A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med 2015; 373:1618-1626. October 22, 2015 PMID: https://pubmed.ncbi.nlm.nih.gov/26488693
  3. ↑ 3.0 3.1 Mitchell SJ, Bernier M, Aon MA, Cortassa S et al Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice. Cell Metab. 2018 Mar 6;27(3):667-676.e4. PMID: https://pubmed.ncbi.nlm.nih.gov/29514072
  4. ↑ 4.0 4.1 4.2 Breglio KF, Knoz KM, Hwang J et al Nicotinamide for Skin Cancer Chemoprevention. JAMA Dermatol 2025. Sept 17 Not yet indexed in PubMed https://jamanetwork.com/journals/jamadermatology/fullarticle/2838591

Database

Retrieved from "https://aaushi.info/w/index.php?title=A17827&oldid=1276340"